Navigation Links
Brooke Shields and the Makers of COPPERTONE(R) Join Together to Launch COPPERTONE(R) NutraShield(TM) - New Sunscreen Contains Antioxidants That Promote Natural Skin Repair
Date:1/27/2009

Dual Defense(TM) Technology Latest Innovation from COPPERTONE(R) Solar Research Center

KENILWORTH, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP), the makers of COPPERTONE(R), announced today that actress and model Brooke Shields will become the spokesperson for the brand's new beauty line, COPPERTONE(R) NutraShield(TM) with Dual Defense(TM) - a broad spectrum sunscreen lotion enriched with antioxidants that promote natural skin repair and combat premature skin aging from the sun.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090127/NY62932)

An international beauty icon, Ms. Shields stays current on the latest trends in maintaining optimal skin health and understands how year-round sun exposure can slowly deplete unprotected skin of its radiance over time. "I am excited to work with the COPPERTONE brand to help raise awareness on the need for year-round sun protection and the benefits of antioxidants in promoting natural skin repair," Shields said.

COPPERTONE(R) Adds Antioxidants to Help Replenish Skin

The COPPERTONE NutraShield product line - the latest innovation from the COPPERTONE Solar Research Center - evolves the brand beyond its suncare roots to a new level of antioxidant-enhanced suncare. The power of NutraShield lies in its Dual Defense technology, combining a broad spectrum sunscreen, to protect against UVA and UVB rays, and antioxidants to replenish skin, supporting its natural repair process.

"The changing environment is altering the way people think about the sun's effects on skin. Our research indicates that consumers want not only broad spectrum sunscreens with higher sun protection factors (SPFs) to help prevent sun damage, but also formulas with antioxidants that can help promote natural skin repair," said Patricia Agin, Ph.D., fellow in skincare research and development at the COPPERTONE Solar Research Center. "Our legacy of continuous innovation led to the development of COPPERTONE NutraShield and its Dual Defense technology, providing women an affordable skin-care option that delivers a high level of sun protection as well as antioxidants to help nourish skin."

The COPPERTONE NutraShield line includes a SPF 70+ Faces lotion as well as SPF 70+ and SPF 30 lotions for the body. The product line is available online and at mass retailers across the country.

About COPPERTONE

COPPERTONE, Water BABIES, COPPERTONE SPORT, ultraGUARD and COPPERTONE KIDS are registered trademarks and NutraShield and Dual Defense are trademarks of Schering-Plough HealthCare Products, Inc.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE:

The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for COPPERTONE(R) NUTRASHIELD(TM). Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the third quarter 2008 10-Q, filed October 29, 2008.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose
3. Col. Robert E. Shields Joins Palmetto GBAs Board of Directors
4. Football helmet shields can protect against a kick in the face
5. Drug Shields Mice From Emphysema
6. Study Shows Exercise Shields Against Osteoporosis
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Equipping your Sales Force to Influence Hospital Formulary Decision-Makers
9. Hospitals and the Coalition to Protect Floridas Drivers Applaud Lawmakers for Reviving No-Fault Insurance
10. Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines
11. Drug Makers Withdraw Cough, Cold Meds for Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced two ... support the company’s continued investment and strategic growth plans in the Asia Pacific ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... supply chain solutions, today announced the organization has earned its ISO 13485 certification, ... and is compliant with all rules and policies associated with ISO quality standard ...
(Date:5/26/2016)... New York, NY (PRWEB) , ... May 26, ... ... cell researcher, founder of Mehling Orthopedics and chief medical officer of Blue Horizon ... Musculoskeletal Disease and Regeneration. The conference was held during May 5-6, 2016 in ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... to oncology professionals, has added National Cancer Institute-designated University of Virginia (UVA) ... In this new partnership, OncLive’s editorial and marketing teams will publicize and promote ...
(Date:5/26/2016)... ... May 26, 2016 , ... Metcalf & ... over 20 years of experience in leading technology and human resources operations for ... university teaching, Morrow-Fox will be featured on Metcalf’s VoiceAmerica radio show , ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... -- Joe Marziani has joined VMS BioMarketing as senior vice president of sales, announced ... role, Marziani will lead the company,s business development and sales team, exploring new opportunities ... Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
(Date:5/24/2016)... , May 24, 2016 Een ... verbindt, zodat zij collectief patiënten kunnen behandelen, hun kennis ... het idee achter de nieuwe en revolutionaire MDLinking App, ... de Nederlandse vaatchirurg dr. Hans Flu en oncologisch chirurg ... die inmiddels beschikbaar is, wordt op dinsdag 24 mei ...
Breaking Medicine Technology: